The association between vibration and vascular injury in rheumatic diseases: A review of the literature

References

• Koch, A., and O. Distler. 2007. Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis. Arthritis. Res. Ther. 9(Suppl 2): S3
   Web of Science ®Google Scholar
• Szekanecz, Z., and A. E. Koch. 2008. Vascular involvement in rheumatic diseases: ‘vascular rheumatology’. Arthritis. Res. Ther. 10: 224
   PubMed Web of Science ®Google Scholar
• Hoffman, G. S. 2008. Disease patterns in vasculitis – still a mystery. Bull. NYU. Hosp. Jt. Dis. 66: 224–227
   PubMedGoogle Scholar
• Broen, J. C., M. J. Coenen, and T. R. Radstake. 2012. Genetics of systemic sclerosis: an update. Curr. Rheumatol. Rep. 14: 11–21
   PubMed Web of Science ®Google Scholar
• Barragán-Martínez, C., C. A. Speck-Hernández, G. Montoya-Ortiz, et al. 2012. Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis. PLoS One. 7: e51506
   PubMed Web of Science ®Google Scholar
• Rook, G. A. 2012. Hygiene hypothesis and autoimmune diseases. Clin. Rev. Allergy. Immunol. 42: 5–15
   PubMed Web of Science ®Google Scholar
• Molina, V., and Y. Shoenfeld. 2005. Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity. 38: 235–245
   PubMed Web of Science ®Google Scholar
• Fridén, J. 2001. Vibration damage to the hand: clinical presentation, prognosis and length and severity of vibration required. J. Hand. Surg. Br. 26: 471–474
   PubMedGoogle Scholar
• Bakst, R., J. F. Merola, A. G. FranksJr, and M. Sanchez. 2008. Raynaud's phenomenon: pathogenesis and managent. J. Am. Acad. Dermatol. 59: 633–653
   PubMed Web of Science ®Google Scholar
• LeRoy, E. C., C. Black, R. Fleischmajer, et al. 1988. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J. Rheumatol. 15: 202–205
   PubMed Web of Science ®Google Scholar
• Botzoris, V., and A. A. Drosos. 2011. Management of Raynaud's phenomenon and digital ulcers in systemic sclerosis. Joint Bone Spine. 78: 341–346
   PubMed Web of Science ®Google Scholar
• Herrick, A. L. 2005. Pathogenesis of Raynaud's phenomenon. Rheumatology (Oxford). 44: 587–596
   PubMed Web of Science ®Google Scholar
• Herrick, A. L. 2012. The pathogenesis, diagnosis and treatment of Raynaud phenomenon. Nat. Rev. Rheumatol. 8: 469–479
   PubMed Web of Science ®Google Scholar
• Wu, S., X. Gao, S. Yang, et al. 2013. Protective effects of cariporide on endothelial dysfunction induced by homocysteine. Pharmacology. 92: 303–309
   PubMed Web of Science ®Google Scholar
• Matucci Cerinic, M., and M. B. Kahaleh. 2002. Beauty and the beast: the nitric oxide paradox in systemic sclerosis. Rheumatology. 41: 843–847
   PubMed Web of Science ®Google Scholar
• Katsumoto, T. R., M. L. Whitfield, and M. K. Connolly. 2011. The pathogenesis of systemic sclerosis. Annu. Rev. Pathol. 6: 509–537
   PubMed Web of Science ®Google Scholar
• Rodnan, G. P., T. G. Benedek, T. A. MedsgerJr., and R. J. Cammarata. 1967. The association of progressive systemic sclerosis (scleroderma) with coal miners pneumoconiosis and other forms of silicosis. Ann. Intern. Med. 66: 323–334
   PubMed Web of Science ®Google Scholar
• Mora, G. F. 2009. Systemic sclerosis: environmental factors. J. Rheumatol. 36: 2383–2396
   PubMed Web of Science ®Google Scholar
• Arefiev, K., D. F. Fiorentino, and L. Chung. 2011. Endothelin receptor antagonists for the treatment of Raynaud's phenomenon and digital ulcers in systemic sclerosis. Int. J. Rheumatol 2011: 201787
   PubMedGoogle Scholar
• Sakurai, T., and K. Goto. 1993. Endothelins: vascular actions and clinical implications. Drugs. 46: 795–804
   PubMed Web of Science ®Google Scholar
• Zamora, M. R., R. F. O'Brien, R. B. Rutherford, and J. V. Weil. 1990. Serum endothelin-1 concentrations and cold provocation in primary Raynaud's phenomenon. Lancet. 336: 1144–1147
   PubMed Web of Science ®Google Scholar
• Ikeda, U., K. Yamamoto, Y. Maeda, et al. 1997. Endothelin-1 inhibits nitric oxide synthesis in vascular smooth muscle cells. Hypertension. 29: 65–69
   PubMed Web of Science ®Google Scholar
• Palmer, K. T., and H. Mason. 1996. Serum endothelin concentrations in workers exposed to vibration. Occup. Environ. Med. 53: 118–124
   PubMed Web of Science ®Google Scholar
• Smyth, A. E., A. L. Bell, I. N. Bruce, et al. 2000. Digital vascular responses and serum endothelin-1 concentrations in primary and secondary Raynaud's phenomenon. Ann. Rheum. Dis. 59: 870–874
   PubMed Web of Science ®Google Scholar
• Kawashiri, S. Y., Y. Ueki, K. Terada, et al. 2013. Improvement of plasma endothelin-1 and nitric oxide in patients with systemic sclerosis by bosentan therapy. Rheumatol. Int 34: 221--225
   PubMed Web of Science ®Google Scholar
• Müller-Ladner, U., O. Distler, L. Ibba-Manneschi, et al. 2009. Mechanisms of vascular damage in systemic sclerosis. Autoimmunity. 42: 587–595
   PubMed Web of Science ®Google Scholar
• Stoyneva, Z., M. Lyapina, D. Tzvetkov, and E. Vodenicharov. 2003. Current pathophysiological views on vibration-induced Raynaud's phenomenon. Cardiovasc. Res. 57: 615–624
   PubMed Web of Science ®Google Scholar
• Kawaguchi, Y., K. Takagi, M. Hara, et al. 2004. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors. Arthritis. Rheum. 50: 216–226
   PubMed Web of Science ®Google Scholar
• Prete, M., M. C. Fatone, E. Favoino, and F. Perosa. 2013. Raynaud's phenomenon: from molecular pathogenesis to therapy. Autoimmun. Rev. 13: 655--667
   Web of Science ®Google Scholar
• Flavahan, N. A., S. Flavahan, S. Mitra, and M. A. Chotani. 2003. The vasculopathy of Raynaud's phenomenon and scleroderma. Rheum. Dis. Clin. North. Am. 29: 275–291
   PubMed Web of Science ®Google Scholar
• Freedman, R. R., M. Moten, P. Migaly, and M. Mayes. 1993. Cold-induced potentiation of α2-adrenergic vasoconstriction in primary Raynaud's. Arthritis. Rheum. 36: 685–690
   PubMedGoogle Scholar
• Freedman, R. R., R. P. Baer, and M. D. Mayes. 1995. Blockade of vasospastic attacks by alpha2-adrenergic but not alpha1-adrenergic antagonists in idiopathic Raynaud's disease. Circulation. 92: 1448–1451
   PubMed Web of Science ®Google Scholar
• Krajnak, K., S. Waugh, C. Johnson, et al. 2009. Vibration disrupts vascular function in a model of metabolic syndrome. Ind. Health. 47: 533–542
   PubMed Web of Science ®Google Scholar
• Saski, N., T. Yamashita, T. Takaya, et al. 2008. Augmentation of vascular remodeling by uncoupled endothelial nitric oxide synthase in a mouse model of diabetes mellitus. Arterioscler. Thromb. Vasc. Biol. 28: 1068–1076
   PubMed Web of Science ®Google Scholar
• Krajnak, K., G. R. Miller, S. Waugh, et al. 2012. Characterization of frequency-dependent responses of the vascular system to repetitive vibration. J. Occup. Environ. Med. 54: 1010–1016
   PubMed Web of Science ®Google Scholar
• Chotani M. A., S. Flavahan, S. Mitra, et al. 2000. Silent α2-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries. Am. J. Physiol. Heart. Circ. Physiol. 278: H1075–H1083
   PubMed Web of Science ®Google Scholar
• Mikulska, D. 2010. Raynaud's phenomenon: pathogenesis and prevalence. Ann. Acad. Med. Stetin. 56: 11–14
   PubMedGoogle Scholar
• Chwieśko-Minarowska, S., K. Kowal, M. Bielecki, and O. Kowal-Bielecka. 2012. The role of Leukotrienes in the pathogenesis of systemic sclerosis. Folia. Histochem. Cytobiol. 50: 180–185
   PubMed Web of Science ®Google Scholar
• Lau, C. S., A. O'Dowd, and J. J. F. Belch. 1992. White blood cell activation in Raynaud's phenomenon of systemic sclerosis and vibration induced white finger syndrome. Am. Rheum. Dis. 51: 249–252
   Google Scholar
• Sunderkötter, C., and G. Riemekasten. 2006. Pathophysiology and clinical consequences of Raynaud's phenomenon related to systemic sclerosis. Rheumatology (Oxford). 45: iii33–iii35
   PubMed Web of Science ®Google Scholar
• Sunderkötter, C., S. Seeliger, F. Schönlau, et al. 2001. Different pathways leading to cutaneous leukocytoclastic vasculitis in mice. Exp. Dermatol. 10: 391–404
   PubMed Web of Science ®Google Scholar
• Pauling, J. D., V. B. O'Donnell, and N. J. Mchugh. 2013. The contribution of platelets to the pathogenesis of Raynaud's phenomenon and systemic sclerosis. Platelets. 24: 503–515
   PubMed Web of Science ®Google Scholar
• Nurden, A. T. 2011. Platelets, inflammation and tissue regeneration. Thromb. Haemost. 105(Suppl 1): S13–S33
   PubMed Web of Science ®Google Scholar
• Fleischmajer, R., and J. S. Perlish. 1980. Capillary alterations in scleroderma. J. Am. Acad. Dermatol. 2: 161–170
   PubMed Web of Science ®Google Scholar
• Verma, S., and T. J. Anderson. 2002. Fundamentals of endothelial function for the clinical cardiologist. Circulation. 105: 546–549
   PubMed Web of Science ®Google Scholar
• Maeda, M., and S. Mori. 1992. Occupational or extrinsic stimulation factors and initial signs of progressive systemic sclerosis. Int. J. Dermatol. 31: 257–259
   PubMed Web of Science ®Google Scholar
• Maugeri, N., S. Franchini, L. Campana, et al. 2012. Circulating platelets as a source of the damage-associated molecular pattern HMGB1 in patients with systemic sclerosis. Autoimmunity. 45: 584–587
   PubMed Web of Science ®Google Scholar
• Madden, J. A. 2012. Role of the vascular endothelium and plaque in acute ischemic stroke. Neurology. 79: S58–S62
   PubMed Web of Science ®Google Scholar
• Hughes, J. M., O. Wirth, K. Krajnak, et al. 2009. Increased oxidant activity mediates vascular Dysfunction in vibration injury. J. Pharmacol. Exp. Ther. 328: 223–230
   PubMed Web of Science ®Google Scholar
• Etienne, S., P. Adamson, J. Greenwood, et al. 1998. ICAM-1 signaling pathways associated with Rho activation in microvascular brain endothelial cells. J. Immunol. 161: 5755–5761
   PubMed Web of Science ®Google Scholar
• Sano, H., and N. Nakagawa. 1998. Cross-linking of intercellular adhesion molecule-1 induces interleukin-8 and RANTES production through the activation of MAP kinases in human vascular endothelial cells. Biochem. Biophys. Res. Commun. 250: 694–698
   PubMed Web of Science ®Google Scholar
• Szekanecz, Z., T. Besenyei, G. Paragh A. E. Koch. 2009. Angiogenesis in rheumatoid arthritis. Autoimmunity. 42: 563–573
   PubMed Web of Science ®Google Scholar
• Pykko, I. 1974. A physiological study of the vasoconstrictive reflex in traumatic vasospastic disease. Work Environ. Health. 11: 170–186
   Google Scholar
• Greenstein, D., P. J. Kent, D. Wilkinson, et al. 1991. Raynaud's phenomenon of occupational origin. J. Hand. Surg. Br. 16: 370–377
   PubMedGoogle Scholar
• Pattanaik, D., M. Brown, and A. E. Postlethwaite. 2011. Vascular involvement in systemic sclerosis (scleroderma). J. Inflamm. Res. 4: 105–125
   PubMedGoogle Scholar
• Hashimoto, K., and R. S. Craig. 1970. Arosclerosis associated with vibration: an electron microscope study. J. Cutan. Pathol. 7: 373–386
   Google Scholar
• Matsumoto, Y., M. Kawabe, T. Yasye, et al. 1989. Two cases of scleroderma associated with vibration syndrome. Nihon. Hifuka. Gakkai. Zasshi. 99: 155–161
   PubMedGoogle Scholar
• Harada, N., I. Hirosawa, H. Dodo, et al. 1981. A case of progressive systemic sclerosis in construction workers-on the effect of exposed vibration at winch operating (author's transl). Sangyo. Igaku. 23: 164–165
   PubMedGoogle Scholar
• Banaszkiewicz, H. 1969. Linear scleroderma in an electric-saw operator. Przegl. Dermatol. 56: 83–86
   PubMedGoogle Scholar
• Erasmus, L. D. 1957. Scleroderma in gold-miners on the Witwatersrand with particular reference to pulmonan-manifestations. S. Atr. J. Lab. Clin. Med. 3: 209–231
   PubMedGoogle Scholar
• Gerkecer Turk, B., A. Urkmez, I. Kilinc Karaarshlan, et al. 2010. Unilateral generalized morphoea: could vibration be a stimulating factor? Clin. Exp. Dermatol. 35: e165–e166
   PubMed Web of Science ®Google Scholar
• Nietert, P. J., and R. M. Silver. 2000. Systemic sclerosis: environmental and occupational risk factors. Curr. Opin. Rheumatol. 12: 520–526
   PubMed Web of Science ®Google Scholar
• Bovenzi, M., F. Barbone, A. Betta, et al. 1995. Scleroderma and occupational exposure. Scand. J. Work Environ. Health. 21: 289–292
   PubMed Web of Science ®Google Scholar
• Bovenzi, M., F. Barbone, F. E. Pisa, et al. 2001. Scleroderma and occupational exposure to hand-transmitted vibration. Int. Arch. Occup. Environ. Health. 74: 579–582
   PubMed Web of Science ®Google Scholar
• Maître, A., M. Hours, V. Bonneterre, et al. 2004. Systemic sclerosis and occupational risk factors: role of solvents and cleaning products. J. Rheumatol. 31: 2395–2401
   PubMed Web of Science ®Google Scholar
• Kütting, B., W. Uter, and H. Drexler. 2006. Is occupational exposure to solvents associated with an increased risk for developing systemic scleroderma? J. Occup. Med Toxicol. 1: 15
   PubMed Web of Science ®Google Scholar
• Thompson, A. E., and J. E. Pope. 2002. Increased prevalence of scleroderma in southwestern Ontario: a cluster analysis. J. Rheumatol. 29: 1867–1873
   PubMed Web of Science ®Google Scholar
• Loriga, G. 1911. A lavoro coi martelli pneumatici. Boll. Inspett. Lavoro. 2: 35
   Google Scholar
• Taylor, W. 1993. The hand–arm vibration syndrome-diagnosis, assessment and objective tests: a review. J. R. Soc. Med. 86: 101–103
   PubMed Web of Science ®Google Scholar
• Rolke, R., S. Rolke, T. Voqt, et al. 2013. Hand–arm vibration syndrome: clinical characteristics, conventional electrophysiology and quantitative sensory testing. Clin. Neurophysiol. 124: 1680–1688
   PubMed Web of Science ®Google Scholar
• Gayraud, M. 2007. Raynaud's phenomenon. Joint Bone Spine. 74: 1–8
   PubMedGoogle Scholar
• Aiba, Y., K. Yamamoto, S. Ohshiba, et al. 2012. A longitudinal study on Raynaud's phenomenon in workers using an impact wrench. J. Occup. Health. 54: 96–102
   PubMed Web of Science ®Google Scholar
• Bovenzi, M. 1998. Exposure–response relationship in the hand–arm vibration syndrome: an overview of current epidemiology research. Int. Arch. Occup. Environ. Health. 71: 509–519
   PubMed Web of Science ®Google Scholar
• Jorulf, L. 1986. Vibration-induced effects caused by impact wrenches used in truck assembly. Scand. J. Work Environ. Health. 12: 269–271
   Web of Science ®Google Scholar
• Griffin, M. J., M. Bovenzi, and C. M. Nelson. 2003. Dose–response patterns for vibration-induced white finger. Occup. Environ. Med. 60: 16–26
   PubMed Web of Science ®Google Scholar
• Harada, N., A. Ueda, and S. Takeqata. 1991. Prevalence of Raynaud's phenomenon in Japanese males and females. J. Clin. Epidemiol. 44: 649–655
   PubMed Web of Science ®Google Scholar
• Blair, H. M. 3rd, J. T. Headington, and P. J. Lynch. 1974. Occupational trauma, Raynaud phenomenon, and sclerodactylia. Arch. Environ. Health. 28: 80–81
   PubMed Web of Science ®Google Scholar
• Nagata, C., H. Yoshida, M. Mirbod, and H. Iwata. 1990. Raynaud's phenomenon and cutaneous changes due to hand–arm vibration. Sangyo. Lgaku. 32: 366–370
   PubMedGoogle Scholar
• Nagata, C., H. Yoshida, S. M. Mirbod, et al. 1993. Cutaneous signs (Raynaud's phenomenon, sclerodactylia, and edema of the hands) and hand–arm vibration exposure. Int. Arch. Occup. Environ. Health. 64: 587–591
   PubMed Web of Science ®Google Scholar
• Olsson, A. R., T. Skogh, and G. Wingren. 2000. Occupational determinants for rheumatoid arthritis. Scand. J. Work Environ. Health. 26: 243–249
   Google Scholar
• Olsson, A. R., T. Skogh, O. Axelson, and G. Wingren. 2004. Occupations and exposures in the work environment as determinants for rheumatoid arthritis. Occup. Environ. Med. 61: 233–238
   PubMed Web of Science ®Google Scholar
• Theriault, G., L. Guire, S. Gingras, and G. Laroche. 1982. Raynaud's phenomenon in forestry workers in Quebec. Can. Med. Assoc. J. 126: 1404–1408
   PubMed Web of Science ®Google Scholar
• Roquelaure, Y., C. Ha, A. P. Le Manac'h, et al. 2012. Risk factors for Raynaud's phenomenon in the workforce. Arthritis. Care Res. (Hoboken). 64: 898–904
   PubMed Web of Science ®Google Scholar
• Dyck, P. J., and C. Giannini. 1996. Pathologic alterations in the diabetic neuropathies of humans: a review. J. Neuropath. Exp. Neurol. 55: 1181–1193
   PubMed Web of Science ®Google Scholar
• Palmer, K. T., S. D'Angelo, H. Syddall, et al. 2014. Dupuytren's contracture and occupational exposure to hand-transmitted vibration. Occup. Environ. Med. 71: 241–245
   PubMed Web of Science ®Google Scholar